with bb2121, is car t-cell therapy ready for myeloma?
Published 6 years ago • 448 plays • Length 8:57Download video MP4
Download video MP3
Similar videos
-
5:46
adam d. cohen, md: expanding car t cells to treat myeloma
-
10:18
ide-cel; bb2121, a bcma-targeted car t-cell therapy, in patients with rrmm: initial karmma results
-
3:17
anti-bcma car t-cells for mm: durable clinical responses with ide-cel (formerly bb2121)
-
3:14
bb2121: bringing car t-cells into the multiple myeloma world
-
3:55
deepu madduri: an emerging car t-cell therapy for myeloma
-
7:06
results from car t-cell bb2121 first-in-human trial for r/r mm
-
5:05
james n. kochenderfer, md: advancing car t-cell therapy for myeloma
-
3:47
what is car t-cell therapy?
-
6:23
late-breaking abstract: first-in-man trial of car t cells in myeloma
-
9:48
the use of car t-cells in multiple myeloma
-
1:53
karmma-4: ide-cel for newly diagnosed high-risk multiple myeloma
-
1:13
car t-cells: targeting bcma
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
2:40
car t-cell therapy to revolutionize multiple myeloma?
-
2:23
improving car t-cell therapy for myeloma
-
6:39
update on bb2121 car t-cell product for mm from eha 2018
-
1:56
ide-cel (formerly bb2121) anti-bcma car t-cell therapy in relapsed/refractory mm
-
0:40
the current status of car t and car nk cells in multiple myeloma
-
2:37
moving forwards with car t-cells in myeloma